Á lódáil...
“Economic Evidence on Identifying Clinically Actionable Findings with Whole Genome Sequencing: A Scoping Review”
BACKGROUND: The American College of Medical Genetics (ACMG) recommends that mutations in 56 genes for 24 conditions are clinically actionable, and should be reported as secondary findings after whole genome sequencing (WGS). Our aim was to identify published economic evaluations of detecting mutatio...
Na minha lista:
| Foilsithe in: | Genet Med |
|---|---|
| Main Authors: | , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
2015
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4654986/ https://ncbi.nlm.nih.gov/pubmed/25996638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gim.2015.69 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|